Product Information

OXCARBAZEPINE 300 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1741 per EA under NDC 72888008801. Its NADAC has been published 159 times since Nov 8, 2023.

FDA first approved this application on Apr 9, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG TABLET

oxcarbazepine
$0.1741per EA

Strength

300 mg/1

NDC

72888008801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077747

FDA Approved

4/9/2008

TE Code

AB

On Market Since

3/19/2021

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 159 times since Nov 8, 2023, and over the history we have for it it has declined 14.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1741 per EA
All-time high$0.2109 (Apr 10, 2024)
All-time low$0.1454 (Nov 20, 2024)
52-week high$0.1745
52-week low$0.1635
Median price$0.1741
Average price$0.1785
Largest weekly change+25.1% (Aug 21, 2024)
Weeks tracked159
Tracking sinceNov 8, 2023

Price History

1W

+1.6%

1M

+1.6%

3M

+6.3%

6M

+4.5%

1Y

-0.2%

3Y

-14.3%

5Y

N/A

All

-14.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1741 per EA (NDC 72888008801), effective Nov 18, 2026.

How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 14.3%. It has been tracked across 159 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?

Since Nov 8, 2023, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1454 (Nov 20, 2024) to a high of $0.2109 (Apr 10, 2024), with a median of $0.1741 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 300 MG TABLET?

OXCARBAZEPINE 300 MG TABLET (NDC 72888008801) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.